Company Filing History:
Years Active: 1987
Title: Gary E. Lord: Innovator in Cephalosporin Synthesis
Introduction
Gary E. Lord is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of cephalosporin antibiotics. With a total of 2 patents, his work has had a meaningful impact on antibiotic development.
Latest Patents
One of Gary's latest patents is focused on the "Synthesis of 3-iodomethyl cephalosporins." This invention provides a process for preparing a 3-iodomethyl cephalosporin by treating a bis(trialkylsilyl)-7-amino-4-carboxylic acid-3-substituted cephalosporin derivative with a trialkylsilyl iodide derivative. Another significant patent is for "Crystalline (7R)-7-amino-3-(1'-pyridiniummethyl)-3-cephem-4-carboxylate." This compound serves as an intermediate in the synthesis of the cephalosporin antibiotic ceftazidime.
Career Highlights
Gary E. Lord is currently associated with Eli Lilly and Company, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing antibiotic therapies, showcasing his expertise and dedication to improving healthcare.
Collaborations
Throughout his career, Gary has collaborated with esteemed colleagues such as Robert M. Metzler and David D. Wirth. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
In summary, Gary E. Lord is a distinguished inventor whose contributions to cephalosporin synthesis have advanced the field of antibiotics. His patents and collaborations reflect his commitment to innovation in healthcare.